Announcements Trials

Browse Landscape

Phase

Status

Completed 9 Terminated 3 Withdrawn 2 Unknown 2 Not yet recruiting 1 Enrolling by invitation 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 40 Breast Neoplasms 40 Prostatic Neoplasms 24 Colorectal Neoplasms 24 Uterine Cervical Neoplasms 16 Carcinoma, Non-Small-Cell Lung 14 Anxiety Disorders 13 Stomach Neoplasms 9 Lymphoma, Follicular 9 Lung Neoplasms 9 Leukemia, Myeloid, Acute 9 Carcinoma, Hepatocellular 8 Brain Neoplasms 8 Urinary Bladder Neoplasms 7 Sarcoma 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Head and Neck Neoplasms 7 Esophageal Squamous Cell Carcinoma 7 Esophageal Neoplasms 7 Ovarian Neoplasms 6 Epilepsy 6 Depression 6 Colonic Neoplasms 6 Uterine Cervical Dysplasia 5 Small Cell Lung Carcinoma 5 Pain 5 Glioma 5 Dementia 5 Cholangiocarcinoma 5 Recurrence 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Enrolling by invitation × Interventional × Exanthema × Clear all

NCT07476807 2026-04-28

TREATS

Sligo General Hospital

Phase NA Enrolling by invitation

Exanthema

Data powered by HemOnc (CC BY 4.0) Colophon ⚡